Gut microbiome-related effects of berberine and probiotics on type 2 diabetes (the PREMOTE study)
The gut microbiome affects systemic metabolism and is a therapeutic target for type 2 diabetes. Here the authors demonstrate in a randomized controlled trial that effects of berberine, a plant alkaloid known to lower blood glucose, may be explained by the inhibition of Ruminococcus bromii mediated b...
Enregistré dans:
Auteurs principaux: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2020
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/74c9d1428bb541f88cc853d5a77532db |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|